Octreotide Lyomark (Octreotide Acetate)

Octreotide Acetate, the active ingredient in Octreotide Lyomark, is a somatostatin analog presented as a sterile solution for subcutaneous injection use. It controls hormone‑related symptoms and tumor‑related secretions in adults with specific endocrine disorders.

GNH USA supplies Octreotide Lyomark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Octreotide Lyomark is a peptide hormone analogue that modulates neuroendocrine activity in several disease groups. - Acromegaly: reduces excessive growth hormone secretion and helps normalise insulin‑like growth factor‑1 levels. - Neuroendocrine tumours (NETs): controls the hormonal hyper‑secretion associated with carcinoid syndrome. - Severe diarrhoea and flushing of carcinoid syndrome: allevi the ab  ab ab ab ab ab ab. - Bleeding  ....

Common ...